IP Library Granted Patent US 10,287,575
Granted Patent B2
US 10,287,575 · App. 15/948,798 · Granted May 14, 2019

Methods for generating barcoded combinatorial libraries

Inventors: Ryan T. Gill (Denver, CO); Andrew Garst (Boulder, CO); Tanya Elizabeth Warnecke Lipscomb (Boulder, CO); Marcelo Colika Bassalo (Boulder, CO); Ramsey Ibrahim Zeitoun (San Francisco, CA)
Assignees: The Regents of the University of Colorado, a body corporate; Inscripta, Inc.
C12N15/1065C12N15/102C12N15/1079C12N15/1082C12N15/11C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,287,575
App. No.
15/948,798
Granted
May 14, 2019
Kind
B2
Abstract

Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engineering. Further provided herein are methods and compositions for enriching for editing and trackable engineered sequences and cells using nucleic acid-guided nucleases.

Claims (47)

1. A method of genome engineering, the method comprising:

contacting a population of cells with a polynucleotide, such that at least one cell uptakes a first single molecule polynucleotide comprising a first editing cassette and a first recorder cassette, wherein:

a),

1) the first editing cassette comprises:

i) a modified first target nucleic acid sequence targeting a first target nucleic acid;

ii) a first protospacer adjacent motif (PAM) mutation;

iii) a first guide nucleic acid sequence targeting the first target nucleic acid and compatible with the nucleic acid-guided nuclease; and

2) the first recorder cassette comprises:

i) a first barcode for tracking and identifying the modified first target nucleic acid sequence; and

ii) a second guide nucleic acid sequence targeting the second target nucleic acid and compatible with the nucleic acid-guided nuclease;

b) allowing the first guide nucleic acid sequence, the second guide nucleic acid sequence, and the nucleic acid-guided nuclease to create a genome edit within the first target nucleic acid and the second target nucleic acid;

c) contacting said at least one cell with at least one additional single molecule polynucleotide comprising a second editing cassette and a second recorder cassette, wherein

3) the second editing cassette comprises:

i) a modified third target nucleic acid sequence targeting a third target nucleic acid:

ii) a second protospacer adjacent motif (PAM) mutation; and

iii) a third guide nucleic acid sequence targeting the third target nucleic acid, and

4) the second recorder cassette comprises:

i) a second barcode for tracking and identifying the modified third target nucleic acid sequence; and

ii) a fourth guide nucleic acid sequence targeting a fourth target nucleic acid, wherein the fourth guide nucleic acid sequence is designed to incorporate the second barcode proximal to the first barcode forming a barcode array; and

d) allowing the third guide nucleic acid sequence, the fourth guide nucleic acid sequence, and the nucleic acid-guided nuclease to create a genome edit within the third target nucleic acid and the fourth target nucleic acid,

wherein the modified first target nucleic acid sequence is different to the modified third nucleic acid sequence, and wherein the second barcode is inserted adjacent to the first barcode, thereby forming a barcode array.

2. The method of claim 1 , further comprising e) sequencing the barcodes in a single reaction, thereby identifying the modified first and third target nucleic acids that were inserted within the first target nucleic acid in a) and c).

3. The method of claim 1 , wherein the first PAM mutation is not recognized by the nucleic acid-guided nuclease.

4. The method of claim 1 , wherein the second recorder cassette further comprises a second PAM mutation that is not recognized by the nucleic acid-guided nuclease.

5. The method of claim 1 , wherein the second recorder cassette targets a unique landing site.

6. The method of claim 1 , wherein the second target nucleic acid comprises a unique landing site.

7. The method of claim 1 ,

wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 7.

8. The method of claim 1 , wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 2.

9. A method of selectable recursive genetic engineering comprising

a) contacting cells comprising a nucleic acid-guided nuclease with a polynucleotide comprising a recorder cassette, said recorder cassette comprising

i) a nucleic acid sequence that recombines into a unique landing site, wherein the nucleic acid sequence comprises a barcode, wherein said barcode is a heterologous sequence engineered into said cells during a first round of said selectable recursive genetic engineering; and

ii) a guide RNA compatible with the nucleic acid-guided nuclease that targets the unique landing site; and

b) allowing the nucleic acid-guided nuclease to edit the unique landing site, thereby incorporating the barcode into the unique landing site;

wherein the nucleic acid-guided nuclease comprises amino acid sequence SEQ ID NO: 2 or SEQ ID NO: 7, and

repeating a) and b) during a second round of said selectable recursive genetic engineering.

10. The method of claim 9 , wherein the nucleic acid sequence further comprises a regulatory sequence that turns transcription of a screenable or selectable marker on or off.

11. The method of claim 9 , wherein the nucleic acid sequence further comprises a PAM mutation that is not compatible with the nucleic acid-guided nuclease.

12. The method of claim 9 , wherein the nucleic acid sequence further comprises a second unique landing site.

13. The method of claim 9 , wherein the polynucleotide further comprises an editing cassette comprising

a) a modified first target nucleic acid sequence;

b) a first protospacer adjacent motif (PAM) mutation; and

c) a first guide nucleic acid sequence targeting the first target nucleic acid,

wherein the modified first target nucleic acid can be tracked and identified by the barcode.

14. The method of claim 13 , wherein the modified first target nucleic acid sequence comprises at least one inserted, deleted, or substituted nucleotide.

15. The method of claim 13 , wherein the modified target nucleic acid sequence is within a coding region of the first target nucleic acid.

16. The method of claim 13 , wherein the modified target nucleic acid sequence is within a non-coding region of the first target nucleic acid.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jun 15, 2021
From: UNIVERSITY OF COLORADO
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 056595/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: LIPSCOMB, TANYA ELIZABETH WARNECKE
To: MUSE BIOTECHNOLOGY, INC.
Reel/Frame 045868/0220 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: GILL, RYAN T.; GARST, ANDREW; BASSALO, MARCELO COLIKA; ZEITOUN, RAMSEY IBRAHIM
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 045868/0240 →
CHANGE OF NAME Recorded May 22, 2018
From: MUSE BIOTECHNOLOGY, INC.
To: INSCRIPTA, INC.
Reel/Frame 046204/0347 →
Continuity (5)
Continuation 15632222 · Jun 23, 2017
Provisional Application 62354516 · Jun 24, 2016
Provisional Application 62367386 · Jul 27, 2016
Provisional Application 62483930 · Apr 10, 2017
Related Publication 20180230461A1 · Aug 16, 2018
Cited By (1)
US 12,195,749